title: Peroxisome proliferator-activated receptor {delta} activators induce IL-8 expression in nonstimulated endothelial cells in a transcriptional and posttranscriptional manner.
abstract: Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are implicated in the regulation of lipid and glucose homeostasis. PPAR agonists have been shown to control inflammatory processes, in part by inhibiting distinct proinflammatory genes (e.g. Il-1β and IFN-γ). IL-8 is a member of the proinflammatory chemokine family that is important for various functions, such as mediating the adhesion of eosinophilic granulocytes onto endothelial cells. The influence of PPARδ activators on the expression of IL-8 in noninduced quiescent endothelial cells is unclear. Therefore, we explored the influence of PPARδ activators on the expression of IL-8 in nonstimulated endothelial cells. PPARδ agonists induce IL-8 expression in human umbilical vein endothelial cells. This induction is demonstrated at the level of both protein and mRNA expression. Transcriptional activation studies using IL-8 reporter gene constructs and DNA binding assays revealed that PPARδ agonists mediated their effects via an NFκB binding site. It is well known that IL-8 is also regulated by mRNA stability. To provide further evidence for this concept, we performed mRNA stability assays and found that PPARδ agonists induce the mRNA stability of IL-8. In addition, we showed that PPARδ agonists induce the phosphorylation of ERK1/2 and p38, which are known to be involved in the increase of mRNA stability. The inhibition of these MAPK signaling pathways resulted in a significant suppression of the induced IL-8 expression and the reduced mRNA stability. Therefore, our data provide the first evidence that PPARδ induces IL-8 expression in nonstimulated endothelial cells via transcriptional as well as posttranscriptional mechanisms.
authors.affiliation: Department of Dermatology, Johann Wolfgang Goethe-Universität, D-60590 Frankfurt am Main, Germany. markus.meissner@kgu.de
authors.forename: Markus
authors.initials: M
authors.lastname: Meissner
authors.forename: Igor
authors.initials: I
authors.lastname: Hrgovic
authors.forename: Monika
authors.initials: M
authors.lastname: Doll
authors.forename: Julia
authors.initials: J
authors.lastname: Naidenow
authors.forename: Gabi
authors.initials: G
authors.lastname: Reichenbach
authors.forename: Tsige
authors.initials: T
authors.lastname: Hailemariam-Jahn
authors.forename: Despina
authors.initials: D
authors.lastname: Michailidou
authors.forename: Jens
authors.initials: J
authors.lastname: Gille
authors.forename: Roland
authors.initials: R
authors.lastname: Kaufmann
mesh_terms: D018925:Chemokines / Q000378:metabolism; D042783:Endothelial Cells / Q000166:cytology*; D004730:Endothelium, Vascular / Q000166:cytology; D005786:Gene Expression Regulation; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007249:Inflammation; D053583:Interleukin-1beta / Q000378:metabolism; D016209:Interleukin-8 / Q000378:metabolism*; D047494:PPAR delta / Q000378:metabolism*; D010766:Phosphorylation; D012323:RNA Processing, Post-Transcriptional; D015398:Signal Transduction; D014158:Transcription, Genetic; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D018925:Chemokines; D053583:Interleukin-1beta; D016209:Interleukin-8; D047494:PPAR delta; D014409:Tumor Necrosis Factor-alpha